PRODUCT DETAILS

About Tacrotreat 1 Tablet

TACROLIMUS belongs to a class of drugs called 'immunosuppressants' used to treat moderate to severe atopic dermatitis (eczema) and prevent organ rejection after a transplant. Atopic dermatitis, also known as eczema is a common skin condition associated with inflamed and itchy skin patches. The symptoms include itchy, dry, flaky, swollen, rough and irritated skin. Organ rejection occurs when a patient’s immune system recognizes the donor organ as foreign and tries to eliminate it. 

TACROLIMUS contains 'Tacrolimus' that works by suppressing the over-reaction of immune cells in the skin to a stimulus. Thereby, reduces allergic reaction and inflammation (redness and swelling). Also, TACROLIMUS suppresses T and B lymphocytes (cells in the immune system) that normally attacks foreign invaders and defend the body against foreign cells and infection. Thereby prevents organ rejection in transplanted patients and helps the body in accepting the new organ.

Uses of Tacrotreat 1 Tablet

Atopic dermatitis (eczema), Organ transplant 

Medicinal Benefits of Tacrotreat 1 Tablet

TACROLIMUS contains Tacrolimus, an immunosuppressant used to treat moderate to severe atopic dermatitis (eczema) and prevent organ rejection after a transplant.  TACROLIMUS suppresses the over-reaction of immune cells in the skin to a stimulus. Thereby, reduces allergic reaction and inflammation (redness and swelling). Also, TACROLIMUS suppresses T and B lymphocytes (cells in the immune system) that normally attacks foreign invaders and defend the body against foreign cells and infection. Thereby prevents organ rejection in transplanted patients and helps the body in accepting the new organ.

Directions for Use

Wash your hands before and after applying TACROLIMUS. The topical form of TACROLIMUS can be applied as a thin layer on the clean and dry affected area of the skin as prescribed by your doctor. TACROLIMUS is only for external use. Please avoid contact with eyes, nose or mouth as it may irritate. In case TACROLIMUS comes in contact with these areas accidentally, rinse with water thoroughly. Take TACROLIMUS on an empty stomach or at least 1 hour before or 2-3 hours after a meal. TACROLIMUS in oral form can be swallowed as a whole with a glass of water. Do not break, chew or crush it. The granules form can be mixed with water just before taking. The injection form of TACROLIMUS is given as an intravenous (into a vein) infusion by a doctor or nurse. Do not self-administer.

Side Effects of Tacrotreat 1 Tablet

• Itching
• Burning sensation
• Redness
• Pain
• Skin tingling
• Nausea
• Diarrhoea
• Headache
• Increased blood sugar levels
• Kidney problems
• Dizziness
• Stomach pain

Similar Drugs

For informational purposes only. Consult a doctor before taking any medicines.

In-Depth Precautions and Warning

Drug-Drug Interaction:

TACROLIMUS may interact with immunosuppressant (ciclosporin), antibiotics (fluconazole, itraconazole, ketoconazole, clotrimazole, voriconazole, erythromycin, clarithromycin, rifampicin), antiemetic (metoclopramide), anticonvulsants (phenytoin, phenobarbital), antacids (lansoprazole, cimetidine, omeprazole), steroid (cortisone, prednisolone, methylprednisolone), antivirals (aciclovir), pain reliever (ibuprofen), an antidepressant (nefazodone), anticancer drugs (imatinib, nilotinib), anti-HIV drugs (nelfinavir, saquinavir, ritonavir).

Safety Advice

ALCOHOL

Avoid alcohol consumption with TACROLIMUS as it may increase the risk of severe adverse effects.

BREAST FEEDING

TACROLIMUS may be excreted in human milk and is not recommended for breastfeeding mothers as it may cause adverse effects in the baby.

DRIVING

TACROLIMUS may cause drowsiness, dizziness or vision problems. Therefore, avoid driving if experience any of these symptoms after taking TACROLIMUS.